Centro de Medicina Nuclear de El Salvador

What Centro de Medicina Nuclear de El Salvador does

Centro de Medicina Nuclear de El Salvador is a private specialty diagnostic and therapeutic nuclear medicine center headquartered at 85 Avenida Norte #345, Colonia Escalón, San Salvador, El Salvador. Founded circa 2004 with over 20 years of claimed operating experience, the center serves patients referred by physicians and those with insurance coverage across multiple specialties: oncology, endocrinology, cardiology, pulmonology, gastroenterology, and nephro-urology. Its flagship capability is PET-CT (Positron Emission Tomography-Computed Tomography), inaugurated in March 2022, making the center the only facility in El Salvador with this imaging modality. The center also operates a Discovery NM630 gamma camera and uses radioisotopes including Tc-99m, I-131, and 18F-FDG for a portfolio of more than 25 diagnostic studies and I-131 therapeutic procedures for thyroid disease and cancer.

The business is structured around a single physical site delivering professional diagnostic and therapeutic services. Revenue is generated through pay-per-procedure billing, with direct-billing arrangements in place with twelve or more insurance providers including Asesuisa, Mapfre, Panamerican Life, Bupa, LaGeo, Sisa, and others, alongside self-pay patients. The center operates under authorization from the Dirección de Protección Radiológica, with zero reported radiological incidents. Its go-to-market is sales-led via physician referral networks and insurance partnerships, augmented by direct patient contact (phone, WhatsApp, email), a content-oriented website, and a Facebook presence for patient engagement.

The clinical team comprises 5 nuclear medicine physicians, 4 specialized technicians, 5 nurses, and administrative staff, supporting the center's claim of zero radiological incidents and its broad service breadth. The center markets itself as a pioneer in radioisotope-based diagnosis and treatment in El Salvador, with a stated value proposition combining exclusive PET-CT access, high-resolution imaging, regulatory compliance, and an integrated diagnostic-to-therapy offering (notably I-131 therapy for thyroid cancer ablation and hyperthyroidism). Ownership is privately held with no disclosed institutional investors, parent company, or funding rounds; no revenue figures are publicly disclosed.

Name

Centro de Medicina Nuclear de El Salvador

Legal name

Centro de Medicina Nuclear de El Salvador

Website

https://medicinanuclearelsalvador.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Centro de Medicina Nuclear de El Salvador is a private nuclear medicine center in San Salvador providing PET-CT, SPECT, and radioiodine therapy services to patients referred across oncology, endocrinology, cardiology, and other specialties, operating as the only PET-CT facility in El Salvador.

Ownership category

akta.pro rank

Product category

Nuclear Medicine Diagnostics

NAICS

Diagnostic Imaging Centers (621512)

akta.pro primary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

akta.pro secondary industry

Diagnostic Radiopharmaceuticals (SPECT/PET Tracers) (HLAIAGAA)

Keywords

• Nuclear medicine services
• PET-CT imaging
• Diagnostic imaging services
• Radioisotope therapy
• Molecular imaging diagnostics

Headquarters

HQ city

Colonia Escalón

HQ country

El Salvador

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Diagnostic Imaging Services: Medical diagnostic services including PET-CT scans, SPECT cardiac studies, thyroid scans, bone scans, and other nuclear medicine procedures for patients referred by physicians or through insurance coverage.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Centro de Medicina Nuclear de El Salvador provides advanced nuclear medicine diagnostic and therapeutic services, including PET-CT imaging, SPECT studies (cardiac, brain, breast), bone scans, thyroid scintigraphy, and radioactive iodine (I-131) therapy for thyroid cancer and hyperthyroidism. The center operates as the only facility in El Salvador equipped with PET-CT technology, delivering molecular imaging and radioisotope-based treatments across oncology, endocrinology, cardiology, pulmonology, gastroenterology, and nephro-urology.

Product overview

Centro de Medicina Nuclear de El Salvador is a specialized nuclear medicine center offering diagnostic and therapeutic services. The center provides PET-CT (Positron Emission Tomography-Computed Tomography) imaging as its flagship technology, being the only facility in the country with this equipment. The core service portfolio includes diagnostic imaging studies using radioactive isotopes (Tc-99m, I-131) and therapeutic treatments (I-131 therapy for thyroid conditions and cancer). Services span multiple medical specialties: Oncology (bone scans, sentinel node biopsy, tumor imaging), Endocrinology (thyroid/parathyroid scans, I-131 therapy), Cardiology (SPECT myocardial perfusion, MUGA ventriculography), Pulmonology (V/Q lung scans), Gastroenterology (esophageal/gastric studies, peritoneal scans), and Nephro-Urology (renograms, testicular scans, cystography). The center also offers additional procedures including brain and breast SPECT, salivary gland imaging, and sentinel lymph node mapping. All services are performed with radiological protection protocols supervised by the Dirección de Protección Radiológica.

Differentiator

Problem solved

Functional benefit

Products and services

• PET-CT Imaging Advanced hybrid imaging combining PET metabolic imaging with CT anatomical imaging for cancer diagnosis, staging, treatment planning, and recurrence monitoring; the only PET-CT equipment in El Salvador.
• Oncology Nuclear Medicine Services Bone scans (Gammagrafía Ósea) and sentinel lymph node biopsy for cancer detection, staging, and management of neoplasms such as breast and prostate cancer.
• Endocrinology Nuclear Medicine Services Thyroid scintigraphy with Tc-99m, I-131 whole-body scans, parathyroid scans, I-131 therapy for hyperthyroidism, and I-131 ablation therapy for differentiated thyroid cancer.
• Cardiology Nuclear Medicine Services SPECT myocardial perfusion imaging (stress and rest) and MUGA ventriculography for coronary artery disease diagnosis and ejection fraction assessment using Tc-99m or Thallium-201.
• Pulmonology Nuclear Medicine Services Ventilation-perfusion (V/Q) lung scans combining Tc-99m DTPA inhalation and Tc-99m MAA injection to diagnose pulmonary thromboembolism and evaluate lung function.
• Gastroenterology Nuclear Medicine Services Esophageal transit studies, gastric emptying scans, ectopic gastric mucosa scans, peritoneal scans, and salivary gland scintigraphy for digestive and functional disorders.
• Nephro-Urology Nuclear Medicine Services Baseline renograms, post-Captopril renograms, diuretic renograms, testicular scintigraphy, and isotopic cystography for renal, urinary, and reproductive system evaluation.
• Other Nuclear Medicine Procedures Brain perfusion SPECT, breast SPECT with SESTAMIBI/Tc-99m, sentinel lymph node lymphography, tumor viability assessment, and three-phase bone scintigraphy.

Quantifiable outcome

• More than 1% better detection of malignant tumors compared to conventional methods
• +2 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered minor.

• AsesuisaminorGTM or Marketing PartnerHealth insurance provider accepted at the center for diagnostic and therapeutic nuclear medicine services.
• MapfreminorGTM or Marketing PartnerMajor insurance provider with network acceptance for nuclear medicine procedures at the center.
• Panamerican LifeminorGTM or Marketing PartnerInternational health insurance provider partnership for nuclear medicine service coverage.
• LaGeominorGTM or Marketing PartnerHealth insurance provider in the center's accepted insurance network.
• BupaminorGTM or Marketing PartnerInternational health insurance company with coverage acceptance at the facility.
• AssaminorGTM or Marketing PartnerInsurance provider accepted for nuclear medicine diagnostic services.
• SisaminorGTM or Marketing PartnerInsurance provider in the center's accepted network.
• ArspalicminorGTM or Marketing PartnerInsurance provider accepted at the nuclear medicine center.
• CELminorGTM or Marketing PartnerInsurance provider in the center's accepted provider network.
• HMminorGTM or Marketing PartnerInsurance provider with coverage acceptance at the facility.
• RPNminorGTM or Marketing PartnerInsurance provider network acceptance for diagnostic services.
• MiredminorGTM or Marketing PartnerInsurance provider accepted for nuclear medicine procedures.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Affidea: European-headquartered outpatient diagnostic imaging and cancer care operator with PET-CT and nuclear medicine capabilities across multiple countries. Comparable as a multi-site advanced imaging chain, though operating in more mature European healthcare systems.
• DASA: Largest diagnostic imaging network in Brazil, offering PET-CT, SPECT, MRI, CT, and lab services across hundreds of sites. Comparable as a scaled outpatient imaging provider, though serving a vastly larger market with broader modality mix.
• Synlab: Europe's largest medical diagnostics services provider with extensive nuclear medicine and imaging capabilities. Comparable as a high-volume specialty diagnostics operator, though vastly larger and operating across regulated European systems.
• Unilabs: International diagnostics and imaging services group operating nuclear medicine and PET-CT centers across Europe and Latin America. Comparable as a multi-country advanced imaging operator, though with broader geographic and modality reach.

Regional players

• IntegraMédica: Chilean outpatient diagnostic imaging network offering CT, MRI, and nuclear medicine studies including bone scans and cardiac SPECT. Comparable as a Latin American imaging chain with insurance-billing infrastructure, though broader in modality and geographic footprint.
• Centro de Diagnóstico por Imagen (CDT): Mexican diagnostic imaging center providing PET-CT, SPECT, and oncology imaging services. Comparable as a Latin American specialty imaging operator serving a similarly structured private/public insurance mix.
• Roe Centro de Diagnóstico: Peruvian diagnostic imaging provider offering nuclear medicine, CT, MRI, and laboratory services. Comparable as a private specialty imaging center in a Latin American emerging market with similar insurance-driven economics.
• Medimagen: Central American / Mexican diagnostic imaging chain offering CT, MRI, and nuclear medicine studies. Comparable as a regional private imaging operator with insurance network acceptance and similar patient demographics.

Emerging players

• Hospital Ángeles (Nuclear Medicine Departments): Mexican private hospital network offering PET-CT and nuclear medicine services at multiple locations. Comparable as a Latin American private-sector provider of advanced nuclear imaging, though embedded within a broader hospital group rather than standalone.

Direct peers

• CEGIN (Centro de Endocrinología, Genética y Medicina Nuclear): Guatemalan nuclear medicine center providing similar diagnostic imaging and radioisotope therapy services in a neighboring Central American market, competing for cross-border referrals and operating under comparable regulatory constraints.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/medicinanuclearsv
• LinkedInlinkedin.com/company/centrodemedicinanuclearsv

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro de Medicina Nuclear de El Salvador